Live Breaking News & Updates on Imdc risk

Overview on Advanced RCC: Epidemiology, Presentation, and Risk Stratification

Explore statistics behind and possible patient presentations of advanced renal cell carcinoma (RCC), with insight into IMDC risk stratification that may influence treatment strategies and outcomes.

Optimizing-therapy , Advanced-renal-cell-carcinoma , Renal-cell-carcinoma , Rcc , Kidney-cancer , Advanced-rcc , Metastatic-kidney-cancer , Clear-cell-rcc , Clear-cell-kidney-cancer , Rcc-signs-and-symptoms , Kidney-cancer-symptoms

Genetic Counseling for Patients with Non-Clear Cell RCC

The panel closes their discussion with a look at the standards for genetic counseling for patients with non-clear cell RCC.

New-wave , Renal-cell-carcinoma , Non-clear-cell , Rcc , Renal-cell-carcinoma-treatment , Asco-gu-2023 , Asco-gu-rcc , Rcc-treatment , Clear-cell-rcc , Non-clear-cell-rcc , Imdc-risk

Best Approaches and Emerging Data in the Treatment of Non-Clear Cell RCC

The panel discusses the best approaches to treating patients with non-clear cell RCC.

New-wave , Renal-cell-carcinoma , Emerging-data , Non-clear-cell , Rcc , Renal-cell-carcinoma-treatment , Asco-gu-2023 , Asco-gu-rcc , Rcc-treatment , Clear-cell-rcc , Non-clear-cell-rcc

Treatment Approaches for Patients with RCC Disease Progression After Adjuvant Therapy

Mehmet Asim Bilen, MD, explains how he would treat a patient with renal cell carcinoma who had disease progression after adjuvant therapy.

Mehmet-asim-bilen , New-wave , Renal-cell-carcinoma , Progression-after-adjuvant , Asim-bilen , Rcc , Renal-cell-carcinoma-treatment , Asco-gu-2023 , Asco-gu-rcc , Rcc-treatment , Clear-cell-rcc

Updates in the Adjuvant Treatment of Metastatic RCC

The panel discusses recent clinical trial data in the adjuvant treatment of metastatic renal cell carcinoma.

New-wave , Renal-cell-carcinoma , Adjuvant-treatment , Rcc , Renal-cell-carcinoma-treatment , Asco-gu-2023 , Asco-gu-rcc , Rcc-treatment , Clear-cell-rcc , Non-clear-cell-rcc , Imdc-risk